Adenocarcinoma of the endometrium treated with combined irradiation and surgery: Study of 437 patients;Adénocarcinome de l'endomètre traité par association radiochirurgicale: À propos de 437 cas

Cancer/Radiotherapie

Volumn 5, Issue 4, 2001, Pages 425-444

  Touboul, E ^a   Belkacemi Y ^a   Buffat, L ^a   Deniaud Alexandre, E ^a   Lefranc, J P ^b   Lhuillier, P ^c   Uzan, S ^a   Jannet, D ^d   Uzan, M ^e   Antoine, M ^a   Ginesty, C ^b   Ganansia, V ^a   Jamali, M ^d   Milliez, J ^d   Blondon, J ^b   Schlienger, M ^a  

^a HÔPITAL TENON   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Centre Hospitalier de Fontainebleau   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e HÔPITAL JEAN VERDIER   (France)

Author keywords

Brachytherapy; Complications; Endometrial carcinoma; Radiotherapy; Risk factors; Surgery; Survival

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADENOCARCINOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPH NODE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

EID: 0034896904     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(01)00113-5     Document Type: Article

References (95)

1. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients
2. Clinical (stage III) as compared to subclinical intra pelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathologic study of 175 patients
3. Aspects of surgery in ovarian and endometrial carcinoma
4. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern
5. Endometrial carcinoma-relative effectiveness of adjuvant irradiation vs therapy reserved for relapse
6. Postoperative radiation therapy for surgically staged endometrial cancer: Impact of time factors (overall treatment time and surgery-to-radiation interval) on outcome
7. Improved outcome in patients treated with postoperative radiation therapy stage I/II endometrial cancer
8. High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer
9. Complications of pelvic lymphadenectomy in patients with endometrial adenocarcinoma
10. Corpus: Epithelial tumors
11. Clinical stage I adenocarcinoma of the endometrium-analysis of recurrences and the potential benefit of staging lymphadenectomy
12. Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990
13. Endometrial carcinoma: Does the addition of intracavitary vault caesium to external beam therapy postoperatively results in improved control or increased morbidity?
14. Pathological prognostic factors in a series of 137 stage I TNM/UICC endometrial carcinomas
15. Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II
16. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: Comparison of clinicopathologic features and survival
17. Good outcome associated with standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium
18. Curiethérapie vaginale postopératoire des adénocarcinomes de l'endomètre à bas débit de dose
19. La plésiocuriethérapie des cancers du vagin par moulage plastique avec l'iridium 192 (préparation non radioactive
20. Facteurs pronostiques du cancer de l'endomètre: À propos de 206 cas traités à l'institut Curie
21. Operative treatment stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri
22. Regression models and life table
23. Surgical pathologic spread patterns of endometrial cancer: A Gynecologic Oncology Group Study
24. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial
25. Treatment of FIGO (1971) stage I endometrial carcinoma with intensive surgery, radiotherapy and hormonotherapy according to pathological prognostic groups. Long-term results of a randomized multicentre study
26. Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: Treatment comparisons
27. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer
28. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trial
29. FIGO stages. 1988 revision (announcement)
30. Uterine papillary serous carcinoma. Complete response of combination chemotherapy
31. Carcinoma of the endometrium
32. Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma
33. Uterine papillary serous carcinoma. A clinical study
34. The value of preoperative or postoperative treatment by radium for carcinoma of the uterine body
35. Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications
36. Analysis of complications in patients with endometrial carcinoma receiving adjuvant irradiation
37. Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation?
38. Is there a role for brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?
39. Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium
40. Clinical stage I endometrial cancer: Results of adjuvant irradiation and patterns of failure
41. The prognostic significance of lymphvascular space invasion in stage I endometrial cancer
42. The importance of peritoneal cytology in endometrial carcinoma
43. Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus
44. Preoperative radiation therapy followed by extrafascial hysterectomy in patients with stage II endometrial carcinoma
45. The prognostic significance of vascular invasion by endometrial carcinoma
46. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: Implications for therapy
47. Angiogenesis in endometrial carcinoma
48. Nonparametric estimation from incomplete observations
49. Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma
50. Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling
51. Absence of prognostic significance, peritoneal dissemination and treatment advantage in endometrial cancer patients with positive peritoneal cytology
52. Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma
53. The justification for a surgical staging system in endometrial carcinoma
54. Pelvic and paraaortic lymphadenectomy for surgical staging of endometrial cancer: Morbidity and mortality
55. Surgery without radiotherapy for primary treatment of endometrial cancer
56. LENT-SOMA scales for all anatomic sites
57. Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer: A comparison of complication rates
58. Adjuvant progestagen therapy in the primary definitive treatment of endometrial cancer
59. Cisplatin-, epirubicin- and paclitaxel- containing chemotherapy in uterine adenocarcinoma
60. Multivariate analysis of DNA ploidy, p53 and HER2/neu as prognostic factors in endometrial cancer
61. A randomized trial of progestagens in the primary treatment of endometrial cancer
62. Preoperative radiotherapy and surgery for endometrial carcinoma: Prognostic significance of the sterilization of the specimen
63. Low stage clear-cell carcinoma of the endometrium
64. Chi-square with one degree of freedom: Extensions of the Mantel-Haenszel procedure
65. Endometrial carcinoma, adjuvant radiotherapy tailored to prognosis factors
66. Doxombicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group Study
67. Relationship between surgical-pathological risk factors and outcome in clinical stage I and stage II carcinoma of the endometrium: A Gynecologic Oncology Group Study
68. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki 67 proliferating cell nuclear antigen, and flow cytometric S-phase fraction
69. Combined surgery and radiation in endometrial carcinoma: An analysis of prognostic factors
70. Postoperative high dose-rate intra-vaginal brachytherapy combined with external irradiation for early stage endometrial cancer: A long-term follow-up
71. Stage I corpus cancer: Is teletherapy necessary?
72. Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer
73. A prospective trial comparing hysterectomy, hysterectomy plus vaginal radium, and uterine radium plus hysterectomy in stage I endometrial carcinoma
74. A prospective trial of postoperative vaginal radium/cesium for grade 1-2 less than 50 % myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma
75. Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma
76. Preoperative whole pelvic external irradiation in stage I endometrial cancer
77. A phase III randomized study of surgery vs surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma (GOG 99)
78. Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma
79. Primary radiation therapy for endometrial carcinoma: A case controlled study
80. Pelvic control following external beam radiation for surgical stage I endometrial carcinoma
81. The management of clinical stage I endometrial carcinoma
82. Analysis of preoperative intracavitary cesium application versus postoperative external beam radiation in stage I endometrial carcinoma
83. Tumor size in endometrial cancer
84. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer
85. Adjuvant external beam therapy for pathologic stage I and occult stage II endometrial cancer
86. Phase III trial of doxorubicin ± cis platin in advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group (GOG) Study
87. Agressive stage I grade 1 endometrial carcinoma
88. Postoperative adjuvant external-beam radiotherapy in surgical stage I endometrial carcinoma
89. 192Ir) and chemotherapy
90. Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma
91. A randomized trial of adjuvant progestagen in early endometrial carcinoma
92. Preoperative radiation therapy in stage I endometrial adenocarcinoma II. Final report of a clinical trial
93. Malignant peritoneal cytology as a prognostic indicator in stage I endometrial cancer
94. Peritoneal washing cytology in gynecologic cancers: Long-term follow-up of 355 patients